Chemokine-receptor polymorphisms: clarity or confusion for HIV-1 prognosis?
- 1 January 1998
- journal article
- editorial
- Published by Elsevier in The Lancet
- Vol. 351 (9095), 2-3
- https://doi.org/10.1016/s0140-6736(98)22001-0
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Early protective effect of CCR-5 Δ32 heterozygosity on HIV-1 disease progressionAIDS, 1997
- The role of viral phenotype and CCR-5 gene defects in HIV-1 transmission and disease progressionNature Medicine, 1997
- Heterozygosity for a deletion in the CKR-5 gene leads to prolonged AIDS-free survival and slower CD4 T-cell decline in a cohort of HIV-seropositive individualsAIDS, 1997
- The role of a mutant CCR5 allele in HIV–1 transmission and disease progressionNature Medicine, 1996
- Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the CKR5 Structural GeneScience, 1996
- Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor geneNature, 1996
- Homozygous Defect in HIV-1 Coreceptor Accounts for Resistance of Some Multiply-Exposed Individuals to HIV-1 InfectionCell, 1996
- HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5Nature, 1996
- Identification of a major co-receptor for primary isolates of HIV-1Nature, 1996
- HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled ReceptorScience, 1996